3 Questions on… Why ‘What’s Old Is New’ in CML 3 Questions on…: Posts, 21 Jul 2015 With Carlo Gambacorti-Passerini, MD, of University of Milano Bicocca “Imatinib mesylate changed the prognosis for chronic…